Runkun Liu

1.8k total citations
46 papers, 1.1k citations indexed

About

Runkun Liu is a scholar working on Molecular Biology, Cancer Research and Control and Systems Engineering. According to data from OpenAlex, Runkun Liu has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Cancer Research and 6 papers in Control and Systems Engineering. Recurrent topics in Runkun Liu's work include Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (14 papers) and Traffic control and management (6 papers). Runkun Liu is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (14 papers) and Traffic control and management (6 papers). Runkun Liu collaborates with scholars based in China, Australia and Kenya. Runkun Liu's co-authors include Tianxiang Chen, Haiyang Yu, Kangsheng Tu, Liankang Sun, Yongshen Niu, Qingguang Liu, Yufeng Wang, Zhikui Liu, Bowen Yao and Huanye Mo and has published in prestigious journals such as British Journal of Cancer, Cell Death and Differentiation and Cellular and Molecular Life Sciences.

In The Last Decade

Runkun Liu

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runkun Liu China 19 563 464 193 156 138 46 1.1k
Zewei Zhou China 16 431 0.8× 251 0.5× 125 0.6× 325 2.1× 69 0.5× 45 1.2k
Liang Tang China 17 282 0.5× 186 0.4× 62 0.3× 28 0.2× 167 1.2× 106 910
Wenchao Ding China 15 162 0.3× 90 0.2× 164 0.8× 306 2.0× 70 0.5× 49 913
Jiaqi Liu China 13 874 1.6× 274 0.6× 13 0.1× 25 0.2× 249 1.8× 69 1.8k
Takashi Takeda Japan 16 280 0.5× 157 0.3× 211 1.1× 80 0.5× 100 0.7× 78 982
Stefano Mariani Italy 13 132 0.2× 94 0.2× 31 0.2× 26 0.2× 158 1.1× 85 723
Hui Feng China 16 276 0.5× 245 0.5× 60 0.3× 21 0.1× 115 0.8× 61 1.1k
Hideaki Nakamura Japan 17 251 0.4× 135 0.3× 52 0.3× 8 0.1× 113 0.8× 68 840
Shifeng Chen China 18 243 0.4× 164 0.4× 20 0.1× 38 0.2× 153 1.1× 73 1.1k

Countries citing papers authored by Runkun Liu

Since Specialization
Citations

This map shows the geographic impact of Runkun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runkun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runkun Liu more than expected).

Fields of papers citing papers by Runkun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runkun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runkun Liu. The network helps show where Runkun Liu may publish in the future.

Co-authorship network of co-authors of Runkun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Runkun Liu. A scholar is included among the top collaborators of Runkun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runkun Liu. Runkun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Tianxiang, Liang Wang, Runkun Liu, et al.. (2023). HIF-1α-activated TMEM237 promotes hepatocellular carcinoma progression via the NPHP1/Pyk2/ERK pathway. Cellular and Molecular Life Sciences. 80(5). 120–120. 7 indexed citations
3.
Wang, Huanhuan, Runkun Liu, Huanye Mo, et al.. (2023). A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection. Frontiers in Oncology. 13. 1133807–1133807. 8 indexed citations
4.
Zhong, Yinghui, Runkun Liu, Bo Mei, et al.. (2023). The Effects and Mechanisms of 2 Mev Proton Irradiation on High Bias Conditions of Inp/Ingaas Dhbts. SSRN Electronic Journal. 2 indexed citations
5.
Zhao, Wei, Huanye Mo, Runkun Liu, et al.. (2022). Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression. British Journal of Cancer. 127(2). 202–210. 18 indexed citations
6.
Chen, Xi, et al.. (2022). Research on Knowledge Graph Modeling Method for Financial Audit of Power Grid Enterprises. 2. 308–314. 2 indexed citations
7.
Liu, Zhikui, Huanye Mo, Runkun Liu, et al.. (2021). Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression. Cell Death and Disease. 12(12). 1134–1134. 49 indexed citations
8.
Chen, Tianxiang, Runkun Liu, Yongshen Niu, et al.. (2021). HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway. Cell Death and Disease. 12(12). 1152–1152. 46 indexed citations
9.
Liu, Runkun, et al.. (2021). Deubiquitinase PSMD7 promotes the proliferation, invasion, and cisplatin resistance of gastric cancer cells by stabilizing RAD23B. International Journal of Biological Sciences. 17(13). 3331–3342. 25 indexed citations
10.
11.
Liu, Yang, Runkun Liu, Junjun Zhao, et al.. (2021). LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis. Journal of Cancer. 12(22). 6805–6813. 5 indexed citations
12.
Shi, Zhan, Runkun Liu, Qiliang Lu, et al.. (2021). UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway. International Journal of Medical Sciences. 18(16). 3749–3758. 16 indexed citations
13.
Wang, Jun, Runkun Liu, Yufeng Wang, et al.. (2021). Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression. Journal of Cancer. 12(17). 5320–5330. 5 indexed citations
14.
Xu, Fan, Yi Zhang, Jing Guan, et al.. (2021). Renal ischemia/reperfusion injury in rats is probably due to the activation of the 5-HT degradation system in proximal renal tubular epithelial cells. Life Sciences. 285. 120002–120002. 8 indexed citations
15.
Wang, Liang, Liankang Sun, Runkun Liu, et al.. (2021). Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Journal of Experimental & Clinical Cancer Research. 40(1). 72–72. 58 indexed citations
16.
Yang, Nan, Tianxiang Chen, Liang Wang, et al.. (2020). CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway. Theranostics. 10(13). 5790–5801. 72 indexed citations
17.
Yang, Nan, Liang Wang, Tianxiang Chen, et al.. (2020). ZNF521 which is downregulated by miR-802 suppresses malignant progression of Hepatocellular Carcinoma through regulating Runx2 expression. Journal of Cancer. 11(19). 5831–5839. 13 indexed citations
18.
Han, Shaoshan, Liang Wang, Liankang Sun, et al.. (2019). MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12. Biomedicine & Pharmacotherapy. 122. 109754–109754. 31 indexed citations
19.
Wang, Liang, Huanye Mo, Yufeng Wang, et al.. (2019). MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3. Biomedicine & Pharmacotherapy. 118. 109267–109267. 21 indexed citations
20.
Sun, Liankang, Yufeng Wang, Liang Wang, et al.. (2019). Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP. Journal of Experimental & Clinical Cancer Research. 38(1). 170–170. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zewei Zhou Breakdown of academic impact, for papers by Liang Tang Breakdown of academic impact, for papers by Wenchao Ding Breakdown of academic impact, for papers by Jiaqi Liu Breakdown of academic impact, for papers by Takashi Takeda Breakdown of academic impact, for papers by Stefano Mariani Breakdown of academic impact, for papers by Hui Feng Breakdown of academic impact, for papers by Hideaki Nakamura Breakdown of academic impact, for papers by Shifeng Chen
Rankless by CCL
2026